269 related articles for article (PubMed ID: 32281421)
1. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges.
Serafino A; Giovannini D; Rossi S; Cozzolino M
Expert Opin Drug Discov; 2020 Jul; 15(7):803-822. PubMed ID: 32281421
[TBL] [Abstract][Full Text] [Related]
2. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.
Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P
Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
[TBL] [Abstract][Full Text] [Related]
4. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders.
Al-Harthi L
J Neuroimmune Pharmacol; 2012 Dec; 7(4):725-30. PubMed ID: 23114888
[TBL] [Abstract][Full Text] [Related]
6. The role of the Wnt canonical signaling in neurodegenerative diseases.
Libro R; Bramanti P; Mazzon E
Life Sci; 2016 Aug; 158():78-88. PubMed ID: 27370940
[TBL] [Abstract][Full Text] [Related]
7. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.
Huang P; Yan R; Zhang X; Wang L; Ke X; Qu Y
Pharmacol Ther; 2019 Apr; 196():79-90. PubMed ID: 30468742
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases.
Gao J; Liao Y; Qiu M; Shen W
Neuroscientist; 2021 Feb; 27(1):58-72. PubMed ID: 32242761
[TBL] [Abstract][Full Text] [Related]
9. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
Jia L; Piña-Crespo J; Li Y
Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease.
Scott EL; Brann DW
Brain Res; 2013 Jun; 1514():63-74. PubMed ID: 23261660
[TBL] [Abstract][Full Text] [Related]
11. WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective.
Ramakrishna K; Nalla LV; Naresh D; Venkateswarlu K; Viswanadh MK; Nalluri BN; Chakravarthy G; Duguluri S; Singh P; Rai SN; Kumar A; Singh V; Singh SK
Diseases; 2023 Jun; 11(3):. PubMed ID: 37489441
[TBL] [Abstract][Full Text] [Related]
12. The role of Wnt signaling in neuroprotection.
Cerpa W; Toledo EM; Varela-Nallar L; Inestrosa NC
Drug News Perspect; 2009 Dec; 22(10):579-91. PubMed ID: 20140278
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders.
Sileo P; Simonin C; Melnyk P; Chartier-Harlin MC; Cotelle P
Cells; 2022 Nov; 11(22):. PubMed ID: 36429058
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
15. Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging.
Duda P; Wiśniewski J; Wójtowicz T; Wójcicka O; Jaśkiewicz M; Drulis-Fajdasz D; Rakus D; McCubrey JA; Gizak A
Expert Opin Ther Targets; 2018 Oct; 22(10):833-848. PubMed ID: 30244615
[TBL] [Abstract][Full Text] [Related]
16. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
[TBL] [Abstract][Full Text] [Related]
17. Nature-derived compounds modulating Wnt/
Sferrazza G; Corti M; Brusotti G; Pierimarchi P; Temporini C; Serafino A; Calleri E
Acta Pharm Sin B; 2020 Oct; 10(10):1814-1834. PubMed ID: 33163337
[TBL] [Abstract][Full Text] [Related]
18. Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
Lecarpentier Y; Vallée A
Front Neurol; 2016; 7():100. PubMed ID: 27445967
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
Marchetti B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
[TBL] [Abstract][Full Text] [Related]
20. β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
Kumawat K; Koopmans T; Gosens R
Expert Opin Ther Targets; 2014 Sep; 18(9):1023-34. PubMed ID: 25005144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
